Showing results (191-200 of 481) with videos related to

Sort By:
Pageof 49
The American Journal of Cardiology|March 4, 2008
Sudden cardiac death in patients with stable coronary artery disease and preserved left ventricular systolic functionJudith Hsia, Kathleen A Jablonski, Madeline Murguia Rice, et al.
European Journal of Heart Failure|March 22, 2019
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)John J V McMurray, David L DeMets, Silvio E Inzucchi, et al.
The New England Journal of Medicine|March 18, 2017
Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseMarc S Sabatine, Robert P Giugliano, Anthony C Keech, et al.
Diabetes, Obesity & Metabolism|July 26, 2024
Risk of new-onset diabetes and efficacy of pharmacological weight loss therapyFilipe A Moura, Andrea Bellavia, David D Berg, et al.
American Journal of Epidemiology|October 9, 2025
Statistical approaches for systematically missing covariates in individual participant data meta-analysis: insights and applications using 5 large cardiovascular trialsRobert Thiesmeier, Paul M Haller, Siddharth M Patel, et al.
JAMA Cardiology|February 14, 2024
Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention PopulationsAeron M Small, Ashley Pournamdari, Giorgio E M Melloni, et al.
American Heart Journal|May 16, 2016
The China Acute Myocardial Infarction (CAMI) Registry: A national long-term registry-research-education integrated platform for exploring acute myocardial infarction in ChinaHaiyan Xu, Wei Li, Jingang Yang, et al.
Journal of the American College of Cardiology|November 16, 2020
Effect of Evolocumab on Complex Coronary Disease Requiring RevascularizationKazuma Oyama, Remo H M Furtado, Antonio Fagundes, et al.
Journal of the American Heart Association|May 6, 2020
Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 TrialBaris Gencer, Xinmin S Li, Yared Gurmu, et al.
American Heart Journal|May 13, 2015
Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trialMichelle L O'Donoghue, Ruchira Glaser, Philip E Aylward, et al.
Pageof 49